Oragenics, Inc.
OGEN
$0.50
-$0.01-2.27%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 2.64% | -28.90% | -41.85% | -74.89% | -75.07% |
| Gross Profit | -2.64% | 28.90% | 41.85% | 74.89% | 75.06% |
| SG&A Expenses | 13.71% | 8.90% | 8.16% | 4.98% | -1.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.83% | -5.26% | -11.33% | -48.90% | -51.52% |
| Operating Income | -9.83% | 5.26% | 11.33% | 48.90% | 51.50% |
| Income Before Tax | 0.11% | 3.37% | 5.57% | 45.38% | 47.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 2.11% | 4.91% | 6.86% | 45.38% | 47.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.11% | 4.91% | 6.86% | 45.38% | 47.22% |
| EBIT | -9.83% | 5.26% | 11.33% | 48.90% | 51.50% |
| EBITDA | -- | -- | -- | 83.24% | 70.57% |
| EPS Basic | 84.45% | 82.63% | 82.40% | 92.97% | 88.99% |
| Normalized Basic EPS | 84.25% | 82.52% | 82.34% | 92.97% | 88.99% |
| EPS Diluted | 84.45% | 82.63% | 82.40% | 92.97% | 88.99% |
| Normalized Diluted EPS | 84.25% | 82.52% | 82.34% | 92.97% | 88.99% |
| Average Basic Shares Outstanding | 552.53% | 558.19% | 517.99% | 524.64% | 414.90% |
| Average Diluted Shares Outstanding | 552.53% | 558.19% | 517.99% | 524.64% | 414.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |